The price, efficacy, and safety of within-class targeted anticancer medicines between domestic and imported drugs in China: a comparative analysisResearch in context
Summary: Background: Affordability to novel anticancer drugs has become a major health issue in China. It is encouraging to note that China initiated its drug regulatory reform and national price negotiation policies since 2015. As a growing number of domestic within-class targeted anticancer drugs...
Saved in:
Main Authors: | Xingxian Luo (Author), Xin Du (Author), Lin Huang (Author), Qixiang Guo (Author), Ruijie Tan (Author), Yue Zhou (Author), Zhuangqi Li (Author), Xuecai Xue (Author), Taifeng Li (Author), Kaidi Le (Author), Feng Qian (Author), Shein-Chung Chow (Author), Yue Yang (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparative analysis of vaccine lists, prices, and candidates, and the national immunization program between China and the United States
by: Xingxian Luo, et al.
Published: (2024) -
Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context
by: Adriana M. Ivama-Brummell, et al.
Published: (2023) -
The study of price situation on the domestic antiplatelet market
by: Ye. А. Redkina, et al.
Published: (2017) -
Health technology assessment-informed pricing negotiation in China: higher negotiated price for more effective targeted anticancer medicines?
by: Cong Huang, et al.
Published: (2022) -
On the Regulatory Approval Pathway of Biosimilar Products
by: Jun Wang, et al.
Published: (2012)